MARKET

ENSC

ENSC

Ensysce Biosciences Inc
NASDAQ
2.570
-0.400
-13.47%
After Hours: 2.590 +0.02 +0.78% 19:44 05/02 EDT
OPEN
2.830
PREV CLOSE
2.970
HIGH
2.910
LOW
2.500
VOLUME
197.55K
TURNOVER
--
52 WEEK HIGH
14.67
52 WEEK LOW
1.620
MARKET CAP
4.23M
P/E (TTM)
-0.2245
1D
5D
1M
3M
1Y
5Y
1D
Ensysce Biosciences files to sell 1.3M shares of common stock for holders
TipRanks · 9h ago
Weekly Report: what happened at ENSC last week (0421-0425)?
Weekly Report · 4d ago
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 04/24 17:05
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 04/24 12:06
3 Penny Stocks to Watch Now, 4/24/25
TipRanks · 04/24 10:27
Why ServiceNow Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket
Benzinga · 04/24 09:30
Ensysce Biosciences announces exercise of warrants for $2.2M gross proceeds
Seeking Alpha · 04/23 21:13
Ensysce Biosciences Stock Doubles In One Trading Session - Here's Why
Benzinga · 04/23 21:11
More
About ENSC
More
Ensysce Biosciences, Inc. is a clinical-stage pharmaceutical company. The Company develops solutions for severe pain relief while reducing the potential for opioid misuse, abuse, and overdose. Its pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, the Trypsin Activated Abuse Protection (TAAP) platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant (MPAR) platform. Its lead product, PF614, is a TAAP extended-release oxycodone and a potential analgesic to treat severe pain. Its second product, PF614-MPAR, is to treat severe pain with the added benefit of oral overdose protection, is a combination product of the TAAP prodrug PF614 with a trypsin inhibitor. Additionally, nafamostat, which is an ingredient in its overdose protection combination products, is also being developed for the intended purpose of treating infection and pulmonary lung diseases.
Recently
Symbol
Price
%Change

Webull offers Ensysce Biosciences Inc stock information, including NASDAQ: ENSC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ENSC stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ENSC stock methods without spending real money on the virtual paper trading platform.